Yasushi Ishida

Prof. Yasushi Ishida

University of Miyazaki, Miyazaki, Japan
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2008 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YOYutaka Ono
Yutaka Ono
SAShuichi Awata
Shuichi Awata
HIHideharu Iida
Hideharu Iida
YIYasushi Ishida
Yasushi Ishida
NINaoki Ishizuka
Naoki Ishizuka
NWNaoki Watanabe
Naoki Watanabe
To respond to the rapid surge in the incidence of suicide in Japan, which appears to be an ongoing trend, the Japanese Multimodal Intervention Trials for Suicide Prevention (J-MISP) have launched a multimodal community-based suicide prevention program, NOCOMIT-J. The primary aim of this study is to examine whether NOCOMIT-J is effective in reducing suicidal behavior in the community. Methods/DesignThis study is a community intervention trial involving seven intervention regions with accompanying control regions, all with populations of statistically sufficient size. The program focuses on building social support networks in the public health system for suicide prevention and mental health promotion, intending to reinforce human relationships in the community. The intervention program components includes a primary prevention measures of awareness campaign for the public and key personnel, secondary prevention measures for screening of, and assisting, high-risk individuals, after-care for individuals bereaved by suicide, and other measures. The intervention started in July 2006, and will continue for 3.5 years. Participants are Japanese and foreign residents living in the intervention and control regions (a total of population of 2,120,000 individuals). The present study is designed to evaluate the effectiveness of the community-based suicide prevention program in the seven participating areas. UMIN Clinical Trials Registry (UMIN-CTR) UMIN000000460.

28 May 2019 in Neuropsychopharmacology Reports
Verified
Journal Article
Open access
PDF file
EKEriko Kuramoto
Eriko Kuramoto
SYSaori Yoshinaga
Saori Yoshinaga
HNHiroyuki Nakao
Hiroyuki Nakao
SNSeiji Nemoto
Seiji Nemoto
YIYasushi Ishida
Yasushi Ishida
Purpose: Facial expressions are formed by the coordination of facial muscles and reflect changes in emotion. Nurses observe facial expressions as way of understanding patients. This study conducted basic research using facial myogenic potential topography to visually determine changes in the location and strength of facial muscle activity associated with voluntary facial expression to examine relationships with facial expressions.Methods: Participants comprised 18 healthy adults (6 men, 12 women; mean age, 24.3 ± 4.3 years). Facial myogenic potentials were measured from 19 electrodes arranged concentrically on the face, and topographic analysis was conducted. Using potential changes and topograms, the muscle activity associated with nonvoluntary facial expression and voluntary facial expressions of happiness and disgust were classified according to the characteristics of expressions. To classify homogeneous groups among the reaction of disgust, hierarchical cluster analysis was utilized.Results: One characteristic of the facial expression of happiness was activity in areas including the greater zygomatic muscle. With the facial expression of disgust, characteristic changes were seen in areas including the corrugator supercilii. Cluster analysis of the expression of disgust showed four homogeneous subgroups.Conclusion: With facial myogenic potential topography, facial expressions can be evaluated objectively without being influenced by face shape or countenance. Color changes in topograms showed subtle changes in expressions that could not be supplemented with statistical processing alone, and these were useful in identifying individuality. Topography is thus expected to be utilized to supplement basic knowledge of facial expressions for a better understanding of patients.

1 May 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YMYu Miyahara
Yu Miyahara
HFHideki Funahashi
Hideki Funahashi
RNRumi Naono-Nakayama
Rumi Naono-Nakayama
AHAyaka Haruta-Tsukamoto
Ayaka Haruta-Tsukamoto
TNToshikazu Nishimori
Toshikazu Nishimori
YIYasushi Ishida
Yasushi Ishida

25 November 2005 in Neuroscience Letters
Verified
Journal Article
Closed access
YIYasushi Ishida
Yasushi Ishida
KKKeiichi Kawai
Keiichi Kawai
YMYasuhiro Magata
Yasuhiro Magata
HAHiroshi Abe
Hiroshi Abe
MYMitsuyoshi Yoshimoto
Mitsuyoshi Yoshimoto
HSHideo Saji
Hideo Saji

1 June 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
RTRyuichiro Takeda
Ryuichiro Takeda
YIYasushi Ishida
Yasushi Ishida
KEKosuke Ebihara
Kosuke Ebihara
HAHiroshi Abe
Hiroshi Abe
HMHisae Matsuo
Hisae Matsuo
TNToshikazu Nishimori
Toshikazu Nishimori

1 September 2020 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YMYu Miyahara
Yu Miyahara
HFHideki Funahashi
Hideki Funahashi
RNRumi Naono-Nakayama
Rumi Naono-Nakayama
AHAyaka Haruta-Tsukamoto
Ayaka Haruta-Tsukamoto
CMChiyo Muroi
Chiyo Muroi
YIYasushi Ishida
Yasushi Ishida